FDA Inspection 1087133 — Lyle Myers, M.D.

Lyle Myers, M.D. — FEI 3015174918

The FDA completed an inspection of Lyle Myers, M.D. on April 23, 2019 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 23, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lexington, KY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance